Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 420.60
Bid: 419.70
Ask: 420.00
Change: 2.50 (0.60%)
Spread: 0.30 (0.071%)
Open: 416.80
High: 421.30
Low: 416.80
Prev. Close: 418.10
RTO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Changes and Appointment of Chairman

28 Feb 2019 07:05

RNS Number : 3508R
Rentokil Initial PLC
28 February 2019
 

28 February 2019

 

Directorate Changes and Appointment of Chairman

 

Appointment of Chairman

Rentokil Initial plc (FTSE: RTO, "the Company") today announces that Richard Solomons will succeed John McAdam as Chairman of the Company. Richard Solomons will join the Board as a Non-Executive Director with effect from 1 March 2019 and, subject to shareholder approval, will become Chairman at the conclusion of the Company's AGM on 8 May 2019, when John McAdam will retire from the Company. John has been Chairman of the Company for over 10 years, over which time the share price rose more than 350% and over £4.5bn of shareholder value was created. Richard will also become a member of the Nomination Committee from his initial date of appointment.

 

Richard is Senior Independent Director and Chair of the Audit Committee of Aston Martin Lagonda Global Holdings plc. Until June 2017, Richard was Chief Executive of InterContinental Hotels Group plc, and prior to that was Chief Financial Officer from IHG's inception as a standalone public company from 2003 to 2011. During his time at IHG Richard also held various finance roles as well as Chief Operating Officer and Interim President of IHG's Americas region. IHG is a global hospitality business with in excess of 5,000 hotels across almost 100 countries, and a diverse portfolio of brands. Richard first joined Bass plc, later Six Continents plc, the company from which IHG emerged, in June 1992 and held a number of finance roles in that organisation, including Finance Director of Britvic Soft Drinks.

 

Prior to joining IHG, Richard worked in investment banking for seven years with Hill Samuel Bank, based in New York and London. Until July 2018 he was a non-executive director of Marks & Spencer Group plc. He also sits on the Board of Governors of the University of Manchester, where he studied Economics, before qualifying as a chartered accountant with KPMG in 1985.

 

Commenting on the appointment, Richard Burrows, the Company's Senior Independent Director who led the planned succession process, said: "I am delighted that Richard Solomons has been chosen to succeed John McAdam as Chairman. We ran a rigorous process to determine the best possible candidate to lead the Board through the exciting next phase of Rentokil Initial's growth. My fellow board members and I are confident that Richard's personal qualities and deep, relevant experience running major global service-led organisations will be a very strong fit for the challenges and opportunities ahead, working with Andy and the executive team."

 

Commenting on the appointment, Andy Ransom, Chief Executive, said "I would like to welcome Richard Solomons to the Board and also to take this opportunity to thank John McAdam for his exemplary leadership of the Board since we joined Rentokil Initial together in 2008. Over the past 10 years, we have made enormous progress in transforming the business from its difficult position in 2008, and positioning it for further success. The support from John and the rest of the Board for the executive team during this period has been exceptional. We can look forward to the future with great optimism, building on the foundations that he helped us lay down."

Other Board Changes

Richard Burrows, Senior Independent Director of the Company and Chair of the Remuneration Committee, has informed the Company that he does not intend to stand for re-election at the Company's AGM on 8 May 2019 and will, therefore, retire as a director of the Company from the conclusion of the meeting. By then, Richard will have served on the Board for a period of 11 years. The Company is pleased to announce that John Pettigrew, a Non-Executive Director since January 2018, will succeed Richard as Senior Independent Director. Angela Seymour-Jackson will become Chair of the Remuneration Committee, having served on the committee since her appointment in March 2012.

 

Commenting on the changes to Board, John McAdam, Chairman of Rentokil Initial, said: "I am very pleased that Richard Solomons has been chosen to succeed me as Chairman, and wish him every success. It has been a great pleasure and privilege to serve on the Board of Rentokil Initial and see the progress in the business that the executive team led by Andy since 2013, and before that by Alan Brown, have delivered for shareholders. I would like to thank Richard Burrows for leading the succession process, and for agreeing to stay on the Board for a few more months to see it through to its conclusion. I'd also like to congratulate John and Angela on their new appointments. I look forward to watching Rentokil Initial go from strength to strength in future."

 

 

 

 

Notes

1. There are no further details to be disclosed relating to Richard Solomons under Section 9.6.13 of the Listing Rules.

2. In line with the Company's current Directors' Remuneration Policy, Richard Solomons will receive a fee of £60,000 p.a. for his appointment as a Non-Executive Director. His fee will be £375,000 p.a. upon his appointment as Chairman.

3. In addition to their Non-Executive Director base fee of £60,000, John Pettigrew will receive an additional fee of £10,000 p.a. as Senior Independent Director and Angela Seymour-Jackson will receive an additional £15,000 p.a. as Chair of the Remuneration Committee.

4. Upon retiring from the Company, John McAdam and Richard Burrows will be entitled to such fees as may have accrued to the date of leaving, together with reimbursement of any expenses properly incurred before that date. No other payments will be made for loss of office.

 

 

 

For further information please contact:

 

Rentokil Initial plc

Media

Malcolm Padley

07788 978199

Company Secretary

Daragh Fagan

01276 607444

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAFMGZZGNNGLZZ
Date   Source Headline
8th May 20242:00 pmRNSResult of AGM
29th Apr 20243:00 pmRNSHolding(s) in Company
23rd Apr 20249:30 amRNSHolding(s) in Company
18th Apr 20247:00 amRNSQ1 Trading Update
2nd Apr 20241:28 pmRNSBlock listing Interim Review
2nd Apr 202412:17 pmRNSTotal Voting Rights
27th Mar 202410:23 amRNSAnnual Financial Report
19th Mar 20242:05 pmRNSAdditional Listing
14th Mar 202410:19 amRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSFinal Results
1st Dec 20237:00 amRNSNorth American Management Changes
10th Nov 20232:28 pmRNSDirector/PDMR Shareholding
3rd Nov 20234:26 pmRNSHolding(s) in Company
3rd Nov 20234:22 pmRNSDirector/PDMR Shareholding
1st Nov 202312:50 pmRNSHolding(s) in Company
31st Oct 202311:45 amRNSHolding(s) in Company
30th Oct 20233:03 pmRNSDirector/PDMR Shareholding
30th Oct 202311:55 amRNSCredit rating update
19th Oct 20237:00 amRNSQ3 Trading Update
2nd Oct 202311:35 amRNSBlock listing Interim Review
27th Sep 20232:35 pmRNSDirector/PDMR Shareholding
1st Aug 202312:42 pmRNSDirector/PDMR Shareholding
27th Jul 20237:00 amRNS2023 Interim Results
29th Jun 20239:00 amRNSNotice of Management Presentation
23rd Jun 20235:58 pmRNSDirector/PDMR Shareholding
19th May 20233:03 pmRNSDirector/PDMR Shareholding
12th May 20239:09 amRNSDirector/PDMR Shareholding
11th May 20239:17 amRNSResult of AGM
28th Apr 202310:55 amRNSHolding(s) in Company
21st Apr 20232:41 pmRNSDirector/PDMR Shareholding
20th Apr 20237:00 amRNSQ1 Trading Update
4th Apr 20239:37 amRNSAnnual Financial Report
3rd Apr 202310:08 amRNSBlock listing Interim Review
23rd Mar 20239:42 amRNSDirector/PDMR Shareholding
20th Mar 20234:47 pmRNSDirector/PDMR Shareholding
16th Mar 20237:05 amRNSDirectorate Change
16th Mar 20237:00 amRNSFinal Results
9th Mar 20239:23 amRNSDirector Declaration
27th Feb 20238:55 amRNSNotice of Management Presentation
9th Nov 20224:33 pmRNSDirector Declaration
1st Nov 20222:25 pmRNSCorrection: Q3 Trading Update
1st Nov 20227:00 amRNSQ3 Trading Update
31st Oct 20224:03 pmRNSTotal Voting Rights
24th Oct 20225:15 pmRNSHolding(s) in Company
21st Oct 20224:42 pmRNSHolding(s) in Company
20th Oct 202212:35 pmRNSHolding(s) in Company
19th Oct 202211:43 amRNSHolding(s) in Company
18th Oct 20225:22 pmRNSHolding(s) in Company
17th Oct 20226:07 pmRNSHolding(s) in Company
17th Oct 202211:51 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.